Latest Insider Transactions at Citius Pharmaceuticals, Inc. (CTXR)
This section provides a real-time view of insider transactions for Citius Pharmaceuticals, Inc. (CTXR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Citius Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Citius Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2024
|
Eugene Myron Holuka Director |
SELL
Payment of exercise price or tax liability
|
Direct |
48
-1.99%
|
$0
$0.75 P/Share
|
|
Mar 13
2024
|
Eugene Myron Holuka Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,415
+50.0%
|
$0
$0.02 P/Share
|
|
Mar 04
2024
|
Carol Webb Director |
SELL
Payment of exercise price or tax liability
|
Direct |
236
-1.96%
|
$0
$0.77 P/Share
|
|
Mar 04
2024
|
Carol Webb Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,071
+50.0%
|
$0
$0.02 P/Share
|